(Q37119295)

18 August 2017

1 reference

title

Metabolic syndrome and stroke. (English)

1 reference

18 August 2017

1 reference

2

Bruce Ovbiagele

1 reference

18 August 2017

Amytis Towfighi

1

1 reference

18 August 2017

publication date

1 February 2008

1 reference

18 August 2017

published in

Current diabetes report

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

37-41

1 reference

Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-008-0008-Z

Insulin resistance and risk for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-008-0008-Z

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-008-0008-Z

Insulin resistance as an independent risk factor for carotid wall thickening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-008-0008-Z

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-008-0008-Z

Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk

21 January 2018

1 reference

12 December 2020

Prevalence of overweight and obesity in the United States, 1999-2004

1 reference

12 December 2020

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

12 December 2020

Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis

1 reference

12 December 2020

Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis.

1 reference

12 December 2020

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes

1 reference

12 December 2020

Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study

1 reference

12 December 2020

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

1 reference

12 December 2020

Current strategies for ischemic stroke prevention: role of multimodal combination therapies

1 reference

12 December 2020

Significant association between leukoaraiosis and metabolic syndrome in healthy subjects

1 reference

12 December 2020

Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study

1 reference

12 December 2020

Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance.

1 reference

12 December 2020

Association of the metabolic syndrome with intracranial atherosclerotic stroke

1 reference

12 December 2020

Asymptomatic atherosclerosis and insulin resistance.

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Current understanding of multiple risk factors as the metabolic syndrome: distillation or deconstruction

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds

1 reference

12 December 2020

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome

1 reference

12 December 2020

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

12 December 2020

Metabolic syndrome increases the risk of ischemic stroke in women

1 reference

12 December 2020

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

1 reference

12 December 2020

The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome

1 reference

12 December 2020

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes

1 reference

12 December 2020

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary

1 reference

12 December 2020

Magnesium intake and incidence of metabolic syndrome among young adults.

1 reference

12 December 2020

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

12 December 2020

Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Metabolic Syndrome Compared With Type 2 Diabetes Mellitus as a Risk Factor for Stroke

1 reference

12 December 2020

High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study

1 reference

12 December 2020

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

1 reference

12 December 2020

10.1007/S11892-008-0008-Z

Identifiers

DOI

1 reference

18 August 2017

1 reference